References
- McLaughlin J., Chianese E., Witte O.N. In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome. Proceedings of the National Academy of Science USA 1987; 84: 6558–6562
- Daley G.Q., Van Etten R.A., Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 1990; 247: 824–830
- Spencer A., O'Brien S.G., Goldman J.M. Options for therapy in chronic myeloid leukaemia. British Journal of Haematology 1995a; 91: 2–7
- The Italian Cooperative Study Group on Chronic Myeloid Leukemia. Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. New England Journal of Medicine 1994; 330: 820–825
- Hehlmann R., Heimpel H., Hasford J., Kolb H.J., Pralle H., Hossfeld D.K., Quiesser W., Loffler H., Hochhaus A., Heinze B., Georgii A., Bartram C.R., Griesshammer M. Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia (CML). Blood 1994; 84: 4064–4077
- Allan N.C., Richards S.M., Shepherd P.C.A. UK Medical Research Council randomised, multicentre trial of interferon-alpha n 1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. Lancet 1995; 345: 1392–1397
- Dowding C., Gordon M., Guo A., Maison D., Osterholz J., Siczkowski M., Goldman J.M. Potential mechanisms of action of interferon-a in CML. Leukemia and Lymphoma 1996; 11: 185–191
- Spencer A., Vulliamy T., Goldman J.M., Melo J.V. Immunoglobulin heavy chain gene rearrangements associated with lymphoid blast crisis of chronic myeloid leukemia: evidence for clonal succession in the B-lymphoid lineage before the onset of blastic transformation. Blood 1995b; 86: 525a, (Abstract)
- Spencer A., Xiu-Hua Y., Chase A., Goldman J.M., Melo J.V. BCR-ABL positive lymphoblastoid cells display limited proliferative capacity under in-vitro culture conditions. British Journal of Haematology 1996; 94: 654–658
- Sokal J.E., Baccarani M., Russo D., Tura S. Staging and prognosis in chronic myelogenous leukemia. Seminars in Hematology 1988; 25: 49–61
- Foroni L., Mason P., Luzzatto L. Immunoglobulin and T-cell receptor gene analysis for the investigation of lymphoproliferative disorders. Churchill Livingstone, Edinburgh 1991; 339
- Cordell J.L., Falini B., Erber W.N., Ghosh A.K., Abdulaziz Z., Macdonald S., Pulford K.A.F., Stein H., Mason D.Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). The Journal of Histochemistry and Cytochemistry 1984; 32: 219–229
- Moir D.J., Ghosh A.K., Abdulaziz Z., Knight P.M., Mason D.Y. Immunoenzymatic staining of haematological samples with monoclonal antibodies. British Journal of Haematology 1983; 55: 395–410
- Bhatia R., McCarthy J.B., Verfaillie C.M. Interferon-a restores normal b1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenviroment in chronic myelogenous leukemia. Blood 1996; 87: 3883–3891
- Gordon M.Y., Dowding C.R., Riley G.P., Goldman J.M., Greaves M.F. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia in chronic phase. Nature 1987; 328: 342–344
- Dowding C., Gou A.P., Osterholz J., Siczkowski M., Goldman J.M. Interferon-a overrides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal elements. Blood 1991; 78: 499–505
- Upadhyaya G., Guba S., Sih S., Feinberg A., Talpaz M., Kantarijian H., Deisseroth A., Emerson S. Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells. Journal of Clinical Investigation 1991; 88: 2131–2136
- Spencer A., Vulliamy T., Kaeda J., Goldman J.M., Melo J.V. Clonal instability preceding lymphoid blastic transformation of chronic myeloid leukemia. Leukemia 1997; 11: 195–201